SCHEMBL8722245

SCHEMBL8722245

CN(C)CCC(O)c1cccc(Br)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.49
HRH1 P35367 4/20 0.46
HTR2A P28223 3/20 0.46
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
SLC18A3 Q16572 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
CHRM2 P08172 3/20 0.39
CHRM1 P11229 3/20 0.39
DRD1 P21728 3/20 0.39
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 3/20 0.39
SLC6A3 Q01959 3/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
TBXA2R P21731 1/20 0.39
OPRM1 P35372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25263568 0.83 AOC3 (0.46) TAAR1HRH1HTR2AMAPTSLC18A3
SCHEMBL31068697 0.83 AOC3 (0.46) TAAR1HRH1HTR2AMAPTSLC18A3
SCHEMBL16765313 0.81 TAAR1 (0.48) TAAR1HRH1HTR2ASLC6A2SLC6A4
SCHEMBL6685361 0.81 SLC18A3 (0.43) ALDH1A1LMNAMAPTSLC18A3SIGMAR1
SCHEMBL29489055 0.80 TAAR1 (0.49) TAAR1HRH1HTR2AALDH1A1LMNA
SCHEMBL10324223 0.80 SLC6A2 (0.49) TAAR1HRH1HTR2AKDM4ESLC6A2
SCHEMBL24369517 0.80 TAAR1 (0.49) TAAR1HRH1HTR2AALDH1A1LMNA
SCHEMBL24369516 0.80 TAAR1 (0.49) TAAR1HRH1HTR2AALDH1A1LMNA
SCHEMBL19742792 0.80 TAAR1 (0.49) TAAR1HRH1HTR2AKMT2ASLC6A2
SCHEMBL4839441 0.79 ALDH1A1 (0.42) ALDH1A1LMNAKDM4EKMT2ASLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12331046-B2 CTPS1 inhibitors and uses thereof NIMBUS CLOTHO, INC. (US) 2025-06-17 US disclosed
EP-4232425-A1 CTPS1 INHIBITORS AND USES THEREOF Nimbus Clotho, Inc. (US) 2023-08-30 EP disclosed
CN-116601131-A CTPS1 inhibitor and application thereof 林伯士克洛索有限公司 2023-08-15 CN disclosed
US-20230077316-A1 CTPS1 INHIBITORS AND USES THEREOF NIMBUS DISCOVERY, INC. 2023-03-09 US disclosed
WO-2022087634-A1 CTPS1 INHIBITORS AND USES THEREOF NIMBUS CLOTHO, INC. (US) 2022-04-28 WO disclosed
WO-2022087634-A1 CTPS1 INHIBITORS AND USES THEREOF NIMBUS CLOTHO, INC. (US) 2022-04-28 WO disclosed
EP-0617006-B1 N-Substituted derivatives of N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine and procedure for their preparation PLIVA PHARM & CHEM WORKS (HR) 1998-05-06 EP disclosed
EP-0391070-B1 Process for the preparation of N-methyl-3-(p-trifluoro-methylphenoxy)-3-phenyl-propylamine and their salts ORION YHTYMAE OY (FI) 1994-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230077316-A1 CTPS1 INHIBITORS AND USES THEREOF CTPS1, CTPS2, ECHS1 TAAR1 4371/4885HRH1 4520/4885HTR2A 4177/4885
US-12331046-B2 CTPS1 inhibitors and uses thereof CTPS1, CTPS2, ECHS1 TAAR1 4371/4885HRH1 4520/4885HTR2A 4177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.